Hookipa Pharma INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
HOOKIPA Pharma Inc. filed an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.
OTC.Pink
HOOKIPA Pharma Inc. reports its 10-K filing for the fiscal year ended December 31, 2024, highlighting pipeline progress, financial results, and a strategic restructuring plan.
OTC.Pink
HOOKIPA Pharma Inc.'s document outlines the details of its registered securities, including common stock, Class A common stock, and preferred stock, under the Securities Exchange Act of 1934.